Switch View
© EQS Newswire
24.10.2025
ISIN: CH1251125998
Relief Therapeutics Holding SA
RLF
LISTED
SIX
Relief Therapeutics Convenes Extraordinary General Meeting
News Preview
Relief Therapeutics Convenes Extraordinary General Meeting
GENEVA (Oct. 24, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief Therapeutics or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced it has convened an e......
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: KYG0330A1013
Alphamab Oncology
9966
LISTED
HKSE
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/αvβ6 Bispecfic ADC JSKN022
News Preview
SUZHOU, China, Oct. 24, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed at Sun Yat-sen University Cancer Center in the phase I clinical study (Study ID: JSKN022-101) of JSKN022, an independently developed innovative bispecific antibody-drug...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development’s portfolio company SVF Vaccines presents positive data from a preclinical study of SVF-001 in chronic hepatitis B and D
News Preview
STOCKHOLM, Sweden, October 24, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has presented positive results from a preclinical study of its immunotherapy SVF-001 targeting chronic hepatitis B and D at the Molecular Biology of HBV meeting in Berlin and the DeltaCure meeting in Hannover....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
24.10.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
49,164 Orion Corporation A shares converted into B shares
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 24 OCTOBER 2025 at 9.00 EEST ...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
24.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press release: Q3: continued sales and earnings progress
News Preview
Q3: continued sales and earnings progress...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US98420X2027
X4 Pharmaceuticals Inc
XFOR
LISTED
NASDAQ
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering
News Preview
BOSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR) (“X4” or the “Company”), a company driven to improve the lives of people with rare hematology diseases, today announced the pricing of its previously announced underwritten public offering of 45,860,000 shares of its common stock at a public offering price per share of $2...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US37733W2044
GSK plc
GSK
LISTED
NYSE
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
News Preview
GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy, including a proteasome inhi...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.10.2025
ISIN: GB00BP2C3V08
Genflow Biosciences Plc
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Holding(s) in Company
News Preview
LONDON, UK / ACCESS Newswire / October 24, 2025 / TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameJonathan Mark SwannCity of...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US2197981051
QuidelOrtho Corp
QDEL
LISTED
NASDAQ
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics
News Preview
SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring George Wierschem, MBA, MT(ASCP), Senior Global Product Manager – Informatics....
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 23, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: CA53946V2066
Lobe Sciences Ltd.
LOBE
LISTED
CSE
Lobe Sciences Completes Debt Settlement to Improve Balance Sheet
News Preview
VANCOUVER, BC / ACCESS Newswire / October 23, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), operates as a pharmaceutical platform that develops novel therapies through a scalable model of shared services, global teams, and outsourced infrastructure. The Company creates intellectual prop...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US4500561067
iRhythm Technologies Inc
IRTC
LISTED
NASDAQ
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.
If you currently own iRhythm stock and acquired shares on or before November 5, 2021, you may be able to seek corporate governance reforms, the return...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
23.10.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics Announces Proposed Public Offering of Common Stock
News Preview
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The Co...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US89422G1076
Travere Therapeutics Inc
TVTX
LISTED
NASDAQ
Travere Therapeutics to Report Third Quarter 2025 Financial Results
News Preview
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 2025, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.
The webcast and dia...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US2036681086
Community Health Systems Inc
CYH
LISTED
NYSE
Community Health Systems, Inc. Announces Third Quarter Ended September 30, 2025 Results
News Preview
Community Health Systems, Inc. (NYSE: CYH) (the “Company”) today announced financial and operating results for the three and nine months ended September 30, 2025.
The following highlights the financial and operating results for the three months ended September 30, 2025.
Net operating revenues totaled $3.087 billion.
Net income attributable...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: DE000A40AEG0
Pentixapharm Holding AG
PTP
LISTED
XETR
Pentixapharm Strengthens Pipeline Prioritization and Improves Cost Structure
News Preview
Pentixapharm Strengthens Pipeline Prioritization and Improves Cost Structure
Company focuses resources on its most advanced clinical development programs while reducing early-stage research activities
Organizational adjustments include a workforce reduction of approximately 50 %, expected to lower operating costs and extend cash runway into Q1......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: DE000A40AEG0
Pentixapharm Holding AG
PTP
LISTED
XETR
Pentixapharm verstärkt Pipeline-Priorisierung und verbessert Kostenstruktur
News Preview
Pentixapharm verstärkt Pipeline-Priorisierung und verbessert Kostenstruktur
Unternehmen fokussiert Ressourcen gezielt auf klinisch am weitesten fortgeschrittene Entwicklungsprogramme und reduziert Aktivitäten in frühen Forschungsphasen
Anpassung der Organisationsstruktur umfasst einen rund 50 %-igen Personalabbau und soll operative Kosten sen......
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US2289031005
Artivion Inc
AORT
LISTED
NYSE
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results
News Preview
ATLANTA, Oct. 23, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the market closes. On that day, the Company will hold a tele...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US74587V1070
Puma Biotechnology Inc
PBYI
LISTED
NASDAQ
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
News Preview
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, Nov. 6, 2025, following the release of its third quarter 2025 financial results.
The call may be accessed by dialing 1-877-709-8150 (domestic) or 1-201-689-8354 (international). Please dial in at least 10 mi...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US45773H4092
Inovio Pharmaceuticals Inc
INO
LISTED
NASDAQ
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
News Preview
PLYMOUTH MEETING, Pa., Oct. 23, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in a virtual fireside c...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US45720N1037
Inhibrx Biosciences Inc
INBX
LISTED
NASDAQ
Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
News Preview
Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful improvement in median progression-free survival compared to placebo
Key secondary endpoints reinforce the primary benefit, demons...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US4576693075
Insmed Inc
INSM
LISTED
NASDAQ
Insmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List
News Preview
—Insmed Leads Science Top Employers List for Fifth Year in a Row—
BRIDGEWATER, N.J., Oct. 23, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
News Preview
CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE) in the Journ...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity Board Declares Quarterly Dividend
News Preview
The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 6, 2026 to all shareholders of record at the close of business on January 16, 2026.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to acti...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US09062W2044
BioLife Solutions Inc
BLFS
LISTED
NASDAQ
BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025
News Preview
BOTHELL, Wash., Oct. 23, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's third quarter 2025 financial results will be released after market close on Thur...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ: SMLR) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 23, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD).
IF YOU ARE AN INVE...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
News Preview
SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), have until Tuesday, December 2, 2025 to seek appointment as...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: CA58490H1073
Medicenna Therapeutics Corp
MDNA
LISTED
TSX
Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025
News Preview
TORONTO and HOUSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune diseases, announced today that updated MDNA11 clinical data will be presented at the European...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: DE000A40AEG0
Pentixapharm Holding AG
PTP
LISTED
XETR
Pentixapharm Focuses Development on Advanced Clinical Programs and Strengthens Financial Position by Discontinuing Preclinical Activities
News Preview
Ad-hoc Disclosure of Inside Information Pursuant to Article 17 Regulation (EU) No. 596/2014
Pentixapharm Focuses Development on Advanced Clinical Programs and Strengthens Financial Position by Discontinuing Preclinical Activities
Berlin, Germany, October 23, 2025 – The Managing Board and Supervisory Board of Pentixapharm Holding AG (Frankf......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: DE000A40AEG0
Pentixapharm Holding AG
PTP
LISTED
XETR
Pentixapharm fokussiert Entwicklung auf fortgeschrittene klinische Programme und stärkt finanzielle Position durch Einstellung präklinischer Aktivitäten
News Preview
Ad-hoc Veröffentlichung einer Insiderinformation nach Art. 17 der Verordnung (EU) Nr. 596/2014
Pentixapharm fokussiert Entwicklung auf fortgeschrittene klinische Programme und stärkt finanzielle Position durch Einstellung präklinischer Aktivitäten
Berlin, Deutschland, 23. Oktober, 2025 – Der Vorstand und Aufsichtsrat der Pentixapharm Holdin......
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
News Preview
NEW YORK, Oct. 23, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US29772L1089
Eton Pharmaceuticals Inc
ETON
LISTED
NASDAQ
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
News Preview
DEER PARK, Ill., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025. Management will...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Securities Fraud Investigation Into Baxter International, Inc. (BAX) Announced – Shareholders Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAX...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US2560861096
DocGo Inc
DCGO
LISTED
NASDAQ
Halper Sadeh LLC Encourages DocGo Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of DocGo Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders.
If you currently own DocGo stock and acquired shares on or before November 5, 2021, you may be able to seek corporate governance reforms, the return of funds back to...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US05380C1027
AVITA Medical Inc
RCEL
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
News Preview
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ: RCEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis ranked #2 Top Employer by Science magazine, recognizing industry-leading scientific innovation and company culture
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the company was named as a top employer to work for by Science magazine in its annual Top Employer survey of the biopharmaceutical and related industries. In its first year of eligibility for the award, Ionis was ranked second based on industry-leading innovation, strong alignment of compa...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US24477E1038
Definitive Healthcare Corp
DH
LISTED
NASDAQ
Definitive Healthcare Announces Timing of Its Third Quarter 2025 Financial Results Conference Call and Webcast
News Preview
FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025 after market close. The company will...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US87918A1051
Teladoc Health Inc
TDOC
LISTED
NYSE
Teladoc Health Announces Chief Financial Officer Transition
News Preview
Provides Preliminary Third Quarter 2025 Consolidated Financial Results, Reaffirms Full-Year 2025 Consolidated Outlook Provides Preliminary Third Quarter 2025 Consolidated Financial Results, Reaffirms Full-Year 2025 Consolidated Outlook...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US89455T1097
Treace Medical Concepts Inc
TMCI
LISTED
NASDAQ
Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
PONTE VEDRA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the third quarter 2025 after the...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics to Report Third Quarter 2025 Financial Results and Host Quarterly Conference Call on November 6, 2025
News Preview
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that it will report its third quarter 2025 financial results and operational highlights after the close of the U.S. financial...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US82657M1053
Sight Sciences Inc
SGHT
LISTED
NASDAQ
Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
MENLO PARK, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced it will report financial results for the...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US0352551081
Anika Therapeutics Inc
ANIK
LISTED
NASDAQ
Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
News Preview
BEDFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2025 financial results before the opening of the market on Wednesday, November 5, 2025, followed by a conference call at 8:30 a.m. ET...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US69380Q1076
PACS Group, Inc.
PACS
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PACS Group, Inc. - PACS
News Preview
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PACS Group, Inc. ("PACS" or the "Company") (NYSE: PACS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Deadline Alert: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Clas...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner
James (Josh) Wilson
Encourages Investors Who Suffered Significant Losses In MoonLake To Contact Him Directly To Discuss Their Options...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options
If you suffered losses in Cytokinetics between December 27, 2023 and May 6, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Savara To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Savara between March 7, 2024 and May 23, 202...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ATYR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in aTyr between January 16, 2025 and September 12...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Molina between February 5, 2025 and July 23,...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Semler Scientific To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Semler Scientific between March 1...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding In LifeMD To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in LifeMD between May 7, 2025 and Aug...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
BAX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Baxter between February 23, 2022 and July 30...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
Faruqi & Faruqi Reminds Tvardi Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 3, 2025 - TVRD
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner
James (Josh) Wilson
Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Lantheus between February 26, 2025 and Aug...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US5747951003
Masimo Corporation
MASI
LISTED
NASDAQ
Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Masimo Corporation (NASDAQ: MASI) breached their fiduciary duties to shareholders.
If you currently own Masimo stock and acquired shares on or before May 4, 2022, you may be able to seek corporate governance reforms, the return of funds back...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Baxter International, Inc. (BAX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BAXTER INTERNATIONAL, INC. (BAX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABO...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: NL0011606264
Merus N.V.
MRUS
LISTED
NASDAQ
Merus Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Merus N.V. (NasdaqGM: MRUS) to Genmab A/S (NasdaqGS: GMAB). Under the terms of the proposed transaction, shareholders of Merus will receive $97.00 in cash for each share of Merus that they ow...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM
News Preview
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
Metsera Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Metsera, Inc. (NasdaqGS: MTSR) to Pfizer Inc. (NYSE: PFE). Under the terms of the proposed transaction, shareholders of Metsera will receive $47.50 per share in cash at closing, plus a non-tr...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
